focus -WSS

focus

author：hotspot 2025-09-27 12:34:27 - browse：72469

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Why Marc Tessier

WSS

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Case highlights the risks of experimental stem cell therapy

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Data integrity in scientific journals requires "effort" by publishers, institutions

'The View' co

Case highlights the risks of experimental stem cell therapy

hotspot

focus

focus

Activists slam private health insurers over coverage restrictions

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Wildfire smoke exposes gaps in outdoor worker protections

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Medicare proposal to cover medical devices draws a mixed reaction

How Brent Saunders' Allergan experiment failed

In age of alternative facts, a scholarly course on calling out crap

Data integrity in scientific journals requires "effort" by publishers, institutions

Wikipedia

Case highlights the risks of experimental stem cell therapy

Pfizer's RSV vaccine recommended for approval in Europe

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Glen Campbell's doctor discusses his public struggle with Alzheimer's

When prostate cancer spreads, where it goes matters

What is artificial intelligence? Experts weigh in

hotspot

Wikipedia

knowledge

hotspot